Aurora Cannabis Inc. (TSE: ACB) (NYSE: ACB) still isn’t a Buy, according to MKM Partners, but the sell-side firm dropped its bear stance on the stock Friday — still saying “issues abound” with the Canadian marijuana company’s outlook.
The Aurora Cannabis Analyst
Bill Kirk upgraded Aurora’s Toronto-listed stock from Sell to Neutral and lowered the fair value estimate from CA$2 ($1.51) to CA$1.75 ($1.32).
The Aurora Cannabis Thesis
Kirk said in a Friday upgrade note that he doesn’t believe Aurora will be profitable by the first quarter of 2021; thinks there will be …